Sign up United Kingdom
Genedrive PLC (LON:GDR)

Genedrive PLC (LON:GDR)

Share Price
21.00 p
-3.5 (-14.29 %)
Market Cap
£3.94 m
Proactive Investors - Run By Investors For Investors

Genedrive PLC RNS Release

Result of AGM

RNS Number : 8820X
Genedrive PLC
29 November 2017

For release: 29 November 2017


genedrive plc ("genedrive" or the "Company")


Result of AGM


genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held in Manchester today, all resolutions proposed were duly passed.


-  Ends  -

For further details please contact:

genedrive plc

+44 (0)161 989 0245

David Budd: CEO

Matthew Fowler: CFO

Peel Hunt LLP

+44 (0)207 418 8900

James Steel

Oliver Jackson

Consilium Strategic Communications

+44 (0)203 709 5700

Chris Gardner

Matthew Neal

Laura Thornton

[email protected]


Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.

Further details can be found at: and 


This information is provided by RNS
The company news service from the London Stock Exchange

Genedrive PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use